tirzepatide gastroparesis case report A newly published series reports that GLP-1 receptor agonists (like semaglutide and tirzepatide) may significantly improve symptoms in patients with mast cell activation syndrome (MCAS), even in those without diabetes or GLP-1 Gastroparesis: Hidden Dangers Beyond

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

When switching from Ozempic or Wegovy to Strive compounded semaglutide, the milligram dose stays the same

As an antioxidant, it prevents damage to important cellular components that arise due to reactive oxygen species like free radicals and peroxide

Looking Ahead Interested to learn more about CGMs

muciniphila -derived bEVs significantly protect streptozotocin (STZ)-induced diabetic mice by regulating glucose homeostasis, attenuating oxidative stress, and inducing immune tolerance, thereby effectively reducing blood glucose levels and ameliorating insulin resistance